Age at onset of type 1 diabetes between puberty and 30 years old is associated with increased diabetic nephropathy risk
Today, semaglutide is widely recognized as one of the most effective non-surgical weight loss tools available
Using advanced options such as Mounjaro, Wegovy, Ozempic, Foundayo, and peptide support, we help individuals work toward sustainable weight management with professional healthcare guidance
As a dual GIP and GLP-1 receptor agonist, tirzepatide simultaneously engages both incretin receptor pathways, differentiating it from single-pathway GLP-1 agents and underpinning the glycemic and weight loss outcomes observed across the SURPASS phase 3 program
Telogen Effluvium and Androgenic Alopecia Rates High Among GLP-1 Receptor Agonist Users [Conference presentation]
At the maximum dose of 15mg per week, that same vial lasts just 2 weeks